Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115344087 | 11534408 | 7 | F | 201505 | 20160919 | 20150922 | 20160926 | PER | PHEH2015US011575 | NOVARTIS | 72.56 | YR | M | Y | 87.90000 | KG | 20160926 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115344087 | 11534408 | 1 | PS | COSENTYX | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QMO | 1130.578 | MG | Y | 125504 | 300 | MG | INJECTION | /month | |||
115344087 | 11534408 | 2 | SS | COSENTYX | SECUKINUMAB | 1 | Unknown | UNK | 1130.578 | MG | Y | 125504 | INJECTION | ||||||
115344087 | 11534408 | 3 | SS | STELARA | USTEKINUMAB | 1 | Unknown | Y | 0 | ||||||||||
115344087 | 11534408 | 4 | C | B COMPLEX//VITAMIN B COMPLEX | 2 | Oral | UNK, QD | U | 0 | QD | |||||||||
115344087 | 11534408 | 5 | C | VITAMIN A | VITAMIN A | 1 | Oral | UNK UNK, QD | U | 0 | QD | ||||||||
115344087 | 11534408 | 6 | C | CLOBETASOL | CLOBETASOL | 1 | Topical | UNK UNK, BID | U | 0 | OINTMENT | BID | |||||||
115344087 | 11534408 | 7 | C | HALOBETASOL | HALOBETASOL PROPIONATE | 1 | Topical | UNK UNK, BID | U | 0 | OINTMENT | BID | |||||||
115344087 | 11534408 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | UNK UNK, BID | U | 0 | BID | ||||||||
115344087 | 11534408 | 9 | C | PRAVACHOL | PRAVASTATIN SODIUM | 1 | Oral | UNK UNK, QD | U | 0 | QD | ||||||||
115344087 | 11534408 | 10 | C | DERMATOP | PREDNICARBATE | 1 | Oral | UNK UNK, BID | U | 0 | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
115344087 | 11534408 | 1 | Psoriasis |
115344087 | 11534408 | 3 | Product used for unknown indication |
115344087 | 11534408 | 4 | Product used for unknown indication |
115344087 | 11534408 | 5 | Product used for unknown indication |
115344087 | 11534408 | 6 | Product used for unknown indication |
115344087 | 11534408 | 7 | Product used for unknown indication |
115344087 | 11534408 | 8 | Product used for unknown indication |
115344087 | 11534408 | 9 | Product used for unknown indication |
115344087 | 11534408 | 10 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
115344087 | 11534408 | Abdominal discomfort | |
115344087 | 11534408 | Abdominal pain lower | |
115344087 | 11534408 | Diarrhoea | |
115344087 | 11534408 | Eructation | |
115344087 | 11534408 | Feeling abnormal | |
115344087 | 11534408 | Gastric disorder | |
115344087 | 11534408 | Gastrooesophageal reflux disease | |
115344087 | 11534408 | Headache | |
115344087 | 11534408 | Paranasal sinus discomfort | |
115344087 | 11534408 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
115344087 | 11534408 | 1 | 20150127 | 20150527 | 0 | |
115344087 | 11534408 | 2 | 20160414 | 0 |